Norovirus-specific immunoglobulin A in breast milk for protection against norovirus-associated diarrhea among infants

Abstract

Background Norovirus (NV) causes acute gastroenteritis in infants. Humoral and fecal immunoglobulin A (IgA) responses have been correlated with protection against NV; however, the role of breast milk IgA against NV infection and associated diarrhea is still unknown. This study aimed to evaluate the protective role of NV-specific IgA (NV-IgA) in breast milk. Methods Ninety-five breast milk samples collected from mothers enrolled in a 2016–2017 Peruvian birth cohort study were tested for total IgA and NV-IgA by ELISA using GII·4 variants and non-GII·4 genotype virus-like particles (VLPs). Breast milk samples were grouped according to the NV infection and diarrheal status of infants: NV positive with diarrhea (NV+D+, n=18); NV positive without diarrhea (NV+D-, n=37); and NV negative without diarrhea (NV-D-, n=40). The percent positivity and titer of NV-IgA were compared among groups. The cross-reactivity was estimated based on the correlation of ratio between NV-IgA against GII·4 variants and non-GII·4 genotype VLPs. Findings NV-IgA had high positivity rates against different VLPs, especially against GII (89–100%). The NV+D- group had higher percent positivity (89% vs. 61%, p=0·03) and median titer (1:100 vs 1:50, p=0·03) of NV-IgA than the NV+D+ group against GI·1 VLPs. A relatively high correlation between different GII·4 variants (0·87) and low correlation between genogroups (0·23–0·37) were observed. Interpretation Mothers with high positivity rates and titers of NV-IgA in breast milk had NV infected infants with reduced diarrheal symptoms. Antigenic relatedness to the genetic diversity of human norovirus was suggested. Funding National Institute of Allergy and Infectious Diseases, National Institute of Health: 1R01AI108695–01A1 and the Japan Society for the Promotion of Science (Fostering Joint International Research B):19KK0241

SARS-CoV-2 Antibodies in Breast Milk After Vaccination

“…This data points to a possible route of infant protection against the virus. The secretion of specific antibodies in naturally immunized mothers has been related to protection against enteric diseases, like Campylobacter, Vibrio cholerae, Salmonella typhimurium, norovirus, etc, [30][31][32][33] as well as a decrease in respiratory infections. 34,35 Other authors have already described the presence of specific IgA and IgG in HM of SARS-CoV-2-infected mothers.…”

COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads

“…However, despite these recommendations and evidence, some mothers have declined vaccination, chosen or been advised to discard their milk for up to 72 hours post vaccine, or decided to stop breastfeeding earlier than planned due to the lack of solid evidence about the effect of the mRNA vaccine on human milk and infant health. An important benefit of human milk is the presence of IgA antibodies that provide passive immunity to the infant 7,8 . In addition, anti-SARS-CoV2 antibodies were recently shown to be present in milk from lactating women that were infected with SARS-CoV2 9,10 .…”

The Antiviral Properties of Human Milk: A Multitude of Defence Tools from Mother Nature

“…This antibody has a dual anti-infective action, providing protection from various microbes and modulating intestinal immunity. The abundance of milk sIgA has long been known for its ability to coat the newborn’s gastrointestinal tract, hindering the binding of some specific microbial agents [ 23 ]. These monoclonal antibodies are produced in the maternal body, mainly from T-dependent B lymphocytes.…”